Align Technology, Inc. (ALGN)
- Previous Close
190.42 - Open
189.53 - Bid 173.81 x 200
- Ask 202.38 x 200
- Day's Range
186.03 - 190.18 - 52 Week Range
141.74 - 283.00 - Volume
165,160 - Avg. Volume
1,309,353 - Market Cap (intraday)
13.572B - Beta (5Y Monthly) 1.68
- PE Ratio (TTM)
34.04 - EPS (TTM)
5.50 - Earnings Date Jul 30, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
227.30
Align Technology, Inc. designs, manufactures, and markets Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally. The Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package to treat adults and teens from mild to severe malocclusion and features, and orthodontic needs of teenage or younger patients; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years with a mixture of primary/baby and permanent teeth. This segment also provides Invisalign express, Invisalign lite, and Invisalign moderate; as well as Invisalign Go, Invisalign Go express, and Invisalign Go Plus; retention products, Invisalign training, adjusting tools used by dental professionals during treatment, ancillary Invisalign accessory products, and other oral health products; Invisalign Professional Whitening system; Invisalign Palatal Expander, a 3D printed orthodontic device; and 3D printing solutions. The Imaging Systems and CAD/CAM Services segment offers iTero intraoral scanning system, a single hardware platform for restorative or orthodontic procedures; exocad, a computer-aided design and computer-aided manufacturing (CAD/CAM) software; orthodontist software for digital records storage, orthodontic diagnosis, and fabrication of printed models and retainers; and restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons. This segment also provides Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; Align Oral Health Suite, a digital interface for dental consultations; iTero TimeLapse technology for doctors or practitioners to compare a patient's historic 3D scans to the present-day scan; and subscription software, disposables, rents scanners, and pay per scan services. The company was incorporated in 1997 and is headquartered in Tempe, Arizona.
www.aligntech.com21,200
Full Time Employees
December 31
Fiscal Year Ends
Sector
Medical Instruments & Supplies
Industry
Recent News: ALGN
View More
Performance Overview: ALGN
Trailing total returns as of 5/14/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ALGN
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ALGN
View MoreValuation Measures
Market Cap
13.80B
Enterprise Value
13.05B
Trailing P/E
34.62
Forward P/E
18.62
PEG Ratio (5yr expected)
1.03
Price/Sales (ttm)
3.57
Price/Book (mrq)
3.64
Enterprise Value/Revenue
3.28
Enterprise Value/EBITDA
16.23
Financial Highlights
Profitability and Income Statement
Profit Margin
10.29%
Return on Assets (ttm)
6.72%
Return on Equity (ttm)
10.84%
Revenue (ttm)
3.98B
Net Income Avi to Common (ttm)
409.56M
Diluted EPS (ttm)
5.50
Balance Sheet and Cash Flow
Total Cash (mrq)
873.01M
Total Debt/Equity (mrq)
3.12%
Levered Free Cash Flow (ttm)
630.04M
Research Analysis: ALGN
View MoreResearch Reports: ALGN
View MoreRating decreased to a HOLD
ALIGN TECHNOLOGY INC has an Investment Rating of HOLD; a target price of $182.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of High.
RatingPrice TargetAlign: Lays Out Five-Year Growth Strategy From Teens, Innovation, and Commercial Excellence
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients’ teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.
RatingPrice TargetAlign Earnings: Weak Consumer Sentiment Doesn’t Slow Down Demand and Market Celebrates Stability
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients’ teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.
RatingPrice TargetRaising target price to $231.00
ALIGN TECHNOLOGY INC has an Investment Rating of BUY; a target price of $231.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of High.
RatingPrice Target